Page last updated: 2024-10-30

manidipine and Epithelial Ovarian Cancer

manidipine has been researched along with Epithelial Ovarian Cancer in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Drug resistance in epithelial ovarian cancer (EOC) is reportedly attributed to the existence of cancer stem cells (CSC), because in most cancers, CSCs still remain after chemotherapy."1.56Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells. ( Choi, DK; Kim, DK; Kim, JH; Kim, JW; Kwon, OB; Lee, DS; Lee, H; Lee, J; Lee, S; Min, SH; Yu, JH, 2020)
"Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy in women worldwide, with an overall 5 year survival rate below 30%."1.56Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness. ( Kim, JW; Lee, DS; Lee, H; Min, SH, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Lee, H2
Kim, JW2
Kim, DK1
Choi, DK1
Lee, S1
Yu, JH1
Kwon, OB1
Lee, J1
Lee, DS2
Kim, JH1
Min, SH2

Other Studies

2 other studies available for manidipine and Epithelial Ovarian Cancer

ArticleYear
Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.
    International journal of molecular sciences, 2020, Mar-27, Volume: 21, Issue:7

    Topics: Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Calcium Channels; Carcinoma,

2020
Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness.
    International journal of molecular sciences, 2020, Oct-06, Volume: 21, Issue:19

    Topics: AC133 Antigen; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ovarian Epithel

2020